Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Inimex Pharmaceuticals Inc.
DescriptionSynthetic 5-amino-acid peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsPrevent bacterial infection; Prevent infections associated with cancer chemotherapy-induced immune suppression; Treat nosocomial infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today